世界のアジソン病用治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Addison's Disease Treatment Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-3763 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、98ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査レポートでは、アジソン病用治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（経口コルチコステロイド、コルチコステロイド注射）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・アジソン病用治療の市場動向 ・企業の競争状況、市場シェア ・アジソン病用治療の種類別市場規模と予測2016-2027（経口コルチコステロイド、コルチコステロイド注射） ・アジソン病用治療の用途別市場規模と予測2016-2027（病院、診療所、その他） ・アジソン病用治療の北米市場規模2016-2027（アメリカ、カナダ） ・アジソン病用治療の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・アジソン病用治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・アジソン病用治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・アジソン病用治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Pfizer、GlaxoSmithKline、Takeda、Abbott Laboratories、Merck、Boehringer Ingelheim、Amgen、Lupin Pharmaceuticals） ・結論

Addison’s disease, also known as primary adrenal insufficiency and hypocortisolism, is a long-term endocrine disorder in which the adrenal glands do not produce enough steroid hormones. Symptoms generally come on slowly and may include abdominal pain, weakness, and weight loss. Darkening of the skin in certain areas may also occur. Under certain circumstances, an adrenal crisis may occur with low blood pressure, vomiting, lower back pain, and loss of consciousness. An adrenal crisis can be triggered by stress, such as from an injury, surgery, or infection.

Market Analysis and Insights: Global Addison’s Disease Treatment Market
The global Addison’s Disease Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Addison’s Disease Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Addison’s Disease Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Addison’s Disease Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Addison’s Disease Treatment market.

Global Addison’s Disease Treatment Scope and Market Size
Addison’s Disease Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Addison’s Disease Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Oral Corticosteroid
Corticosteroid Injections

Segment by Application
Hospitals
Clinics
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Pfizer
GlaxoSmithKline
Takeda
Abbott Laboratories
Merck
Boehringer Ingelheim
Amgen
Lupin Pharmaceuticals

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Addison’s Disease Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Oral Corticosteroid
1.2.3 Corticosteroid Injections
1.3 Market by Application
1.3.1 Global Addison’s Disease Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Addison’s Disease Treatment Market Perspective (2016-2027)
2.2 Addison’s Disease Treatment Growth Trends by Regions
2.2.1 Addison’s Disease Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Addison’s Disease Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Addison’s Disease Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Addison’s Disease Treatment Industry Dynamic
2.3.1 Addison’s Disease Treatment Market Trends
2.3.2 Addison’s Disease Treatment Market Drivers
2.3.3 Addison’s Disease Treatment Market Challenges
2.3.4 Addison’s Disease Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Addison’s Disease Treatment Players by Revenue
3.1.1 Global Top Addison’s Disease Treatment Players by Revenue (2016-2021)
3.1.2 Global Addison’s Disease Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Addison’s Disease Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Addison’s Disease Treatment Revenue
3.4 Global Addison’s Disease Treatment Market Concentration Ratio
3.4.1 Global Addison’s Disease Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Addison’s Disease Treatment Revenue in 2020
3.5 Addison’s Disease Treatment Key Players Head office and Area Served
3.6 Key Players Addison’s Disease Treatment Product Solution and Service
3.7 Date of Enter into Addison’s Disease Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Addison’s Disease Treatment Breakdown Data by Type
4.1 Global Addison’s Disease Treatment Historic Market Size by Type (2016-2021)
4.2 Global Addison’s Disease Treatment Forecasted Market Size by Type (2022-2027)

5 Addison’s Disease Treatment Breakdown Data by Application
5.1 Global Addison’s Disease Treatment Historic Market Size by Application (2016-2021)
5.2 Global Addison’s Disease Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Addison’s Disease Treatment Market Size (2016-2027)
6.2 North America Addison’s Disease Treatment Market Size by Type
6.2.1 North America Addison’s Disease Treatment Market Size by Type (2016-2021)
6.2.2 North America Addison’s Disease Treatment Market Size by Type (2022-2027)
6.2.3 North America Addison’s Disease Treatment Market Size by Type (2016-2027)
6.3 North America Addison’s Disease Treatment Market Size by Application
6.3.1 North America Addison’s Disease Treatment Market Size by Application (2016-2021)
6.3.2 North America Addison’s Disease Treatment Market Size by Application (2022-2027)
6.3.3 North America Addison’s Disease Treatment Market Size by Application (2016-2027)
6.4 North America Addison’s Disease Treatment Market Size by Country
6.4.1 North America Addison’s Disease Treatment Market Size by Country (2016-2021)
6.4.2 North America Addison’s Disease Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Addison’s Disease Treatment Market Size (2016-2027)
7.2 Europe Addison’s Disease Treatment Market Size by Type
7.2.1 Europe Addison’s Disease Treatment Market Size by Type (2016-2021)
7.2.2 Europe Addison’s Disease Treatment Market Size by Type (2022-2027)
7.2.3 Europe Addison’s Disease Treatment Market Size by Type (2016-2027)
7.3 Europe Addison’s Disease Treatment Market Size by Application
7.3.1 Europe Addison’s Disease Treatment Market Size by Application (2016-2021)
7.3.2 Europe Addison’s Disease Treatment Market Size by Application (2022-2027)
7.3.3 Europe Addison’s Disease Treatment Market Size by Application (2016-2027)
7.4 Europe Addison’s Disease Treatment Market Size by Country
7.4.1 Europe Addison’s Disease Treatment Market Size by Country (2016-2021)
7.4.2 Europe Addison’s Disease Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Addison’s Disease Treatment Market Size (2016-2027)
8.2 Asia-Pacific Addison’s Disease Treatment Market Size by Type
8.2.1 Asia-Pacific Addison’s Disease Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Addison’s Disease Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Addison’s Disease Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Addison’s Disease Treatment Market Size by Application
8.3.1 Asia-Pacific Addison’s Disease Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Addison’s Disease Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Addison’s Disease Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Addison’s Disease Treatment Market Size by Region
8.4.1 Asia-Pacific Addison’s Disease Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Addison’s Disease Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Addison’s Disease Treatment Market Size (2016-2027)
9.2 Latin America Addison’s Disease Treatment Market Size by Type
9.2.1 Latin America Addison’s Disease Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Addison’s Disease Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Addison’s Disease Treatment Market Size by Type (2016-2027)
9.3 Latin America Addison’s Disease Treatment Market Size by Application
9.3.1 Latin America Addison’s Disease Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Addison’s Disease Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Addison’s Disease Treatment Market Size by Application (2016-2027)
9.4 Latin America Addison’s Disease Treatment Market Size by Country
9.4.1 Latin America Addison’s Disease Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Addison’s Disease Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Addison’s Disease Treatment Market Size (2016-2027)
10.2 Middle East & Africa Addison’s Disease Treatment Market Size by Type
10.2.1 Middle East & Africa Addison’s Disease Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Addison’s Disease Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Addison’s Disease Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Addison’s Disease Treatment Market Size by Application
10.3.1 Middle East & Africa Addison’s Disease Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Addison’s Disease Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Addison’s Disease Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Addison’s Disease Treatment Market Size by Country
10.4.1 Middle East & Africa Addison’s Disease Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Addison’s Disease Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Addison’s Disease Treatment Introduction
11.1.4 Pfizer Revenue in Addison’s Disease Treatment Business (2016-2021)
11.1.5 Pfizer Recent Development
11.2 GlaxoSmithKline
11.2.1 GlaxoSmithKline Company Details
11.2.2 GlaxoSmithKline Business Overview
11.2.3 GlaxoSmithKline Addison’s Disease Treatment Introduction
11.2.4 GlaxoSmithKline Revenue in Addison’s Disease Treatment Business (2016-2021)
11.2.5 GlaxoSmithKline Recent Development
11.3 Takeda
11.3.1 Takeda Company Details
11.3.2 Takeda Business Overview
11.3.3 Takeda Addison’s Disease Treatment Introduction
11.3.4 Takeda Revenue in Addison’s Disease Treatment Business (2016-2021)
11.3.5 Takeda Recent Development
11.4 Abbott Laboratories
11.4.1 Abbott Laboratories Company Details
11.4.2 Abbott Laboratories Business Overview
11.4.3 Abbott Laboratories Addison’s Disease Treatment Introduction
11.4.4 Abbott Laboratories Revenue in Addison’s Disease Treatment Business (2016-2021)
11.4.5 Abbott Laboratories Recent Development
11.5 Merck
11.5.1 Merck Company Details
11.5.2 Merck Business Overview
11.5.3 Merck Addison’s Disease Treatment Introduction
11.5.4 Merck Revenue in Addison’s Disease Treatment Business (2016-2021)
11.5.5 Merck Recent Development
11.6 Boehringer Ingelheim
11.6.1 Boehringer Ingelheim Company Details
11.6.2 Boehringer Ingelheim Business Overview
11.6.3 Boehringer Ingelheim Addison’s Disease Treatment Introduction
11.6.4 Boehringer Ingelheim Revenue in Addison’s Disease Treatment Business (2016-2021)
11.6.5 Boehringer Ingelheim Recent Development
11.7 Amgen
11.7.1 Amgen Company Details
11.7.2 Amgen Business Overview
11.7.3 Amgen Addison’s Disease Treatment Introduction
11.7.4 Amgen Revenue in Addison’s Disease Treatment Business (2016-2021)
11.7.5 Amgen Recent Development
11.8 Lupin Pharmaceuticals
11.8.1 Lupin Pharmaceuticals Company Details
11.8.2 Lupin Pharmaceuticals Business Overview
11.8.3 Lupin Pharmaceuticals Addison’s Disease Treatment Introduction
11.8.4 Lupin Pharmaceuticals Revenue in Addison’s Disease Treatment Business (2016-2021)
11.8.5 Lupin Pharmaceuticals Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Addison's Disease Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Oral Corticosteroid
Table 3. Key Players of Corticosteroid Injections
Table 4. Global Addison's Disease Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Addison's Disease Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Addison's Disease Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Addison's Disease Treatment Market Share by Regions (2016-2021)
Table 8. Global Addison's Disease Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Addison's Disease Treatment Market Share by Regions (2022-2027)
Table 10. Addison's Disease Treatment Market Trends
Table 11. Addison's Disease Treatment Market Drivers
Table 12. Addison's Disease Treatment Market Challenges
Table 13. Addison's Disease Treatment Market Restraints
Table 14. Global Addison's Disease Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Addison's Disease Treatment Market Share by Players (2016-2021)
Table 16. Global Top Addison's Disease Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Addison's Disease Treatment as of 2020)
Table 17. Ranking of Global Top Addison's Disease Treatment Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Addison's Disease Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Addison's Disease Treatment Product Solution and Service
Table 21. Date of Enter into Addison's Disease Treatment Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Addison's Disease Treatment Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Addison's Disease Treatment Revenue Market Share by Type (2016-2021)
Table 25. Global Addison's Disease Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Addison's Disease Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Addison's Disease Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Addison's Disease Treatment Revenue Market Share by Application (2016-2021)
Table 29. Global Addison's Disease Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Addison's Disease Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Addison's Disease Treatment Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Addison's Disease Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Addison's Disease Treatment Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Addison's Disease Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Addison's Disease Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Addison's Disease Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Addison's Disease Treatment Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Addison's Disease Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Addison's Disease Treatment Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Addison's Disease Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Addison's Disease Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Addison's Disease Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Addison's Disease Treatment Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Addison's Disease Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Addison's Disease Treatment Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Addison's Disease Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Addison's Disease Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Addison's Disease Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Addison's Disease Treatment Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Addison's Disease Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Addison's Disease Treatment Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Addison's Disease Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Addison's Disease Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Addison's Disease Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Addison's Disease Treatment Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Addison's Disease Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Addison's Disease Treatment Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Addison's Disease Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Addison's Disease Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Addison's Disease Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 61. Pfizer Company Details
Table 62. Pfizer Business Overview
Table 63. Pfizer Addison's Disease Treatment Product
Table 64. Pfizer Revenue in Addison's Disease Treatment Business (2016-2021) & (US$ Million)
Table 65. Pfizer Recent Development
Table 66. GlaxoSmithKline Company Details
Table 67. GlaxoSmithKline Business Overview
Table 68. GlaxoSmithKline Addison's Disease Treatment Product
Table 69. GlaxoSmithKline Revenue in Addison's Disease Treatment Business (2016-2021) & (US$ Million)
Table 70. GlaxoSmithKline Recent Development
Table 71. Takeda Company Details
Table 72. Takeda Business Overview
Table 73. Takeda Addison's Disease Treatment Product
Table 74. Takeda Revenue in Addison's Disease Treatment Business (2016-2021) & (US$ Million)
Table 75. Takeda Recent Development
Table 76. Abbott Laboratories Company Details
Table 77. Abbott Laboratories Business Overview
Table 78. Abbott Laboratories Addison's Disease Treatment Product
Table 79. Abbott Laboratories Revenue in Addison's Disease Treatment Business (2016-2021) & (US$ Million)
Table 80. Abbott Laboratories Recent Development
Table 81. Merck Company Details
Table 82. Merck Business Overview
Table 83. Merck Addison's Disease Treatment Product
Table 84. Merck Revenue in Addison's Disease Treatment Business (2016-2021) & (US$ Million)
Table 85. Merck Recent Development
Table 86. Boehringer Ingelheim Company Details
Table 87. Boehringer Ingelheim Business Overview
Table 88. Boehringer Ingelheim Addison's Disease Treatment Product
Table 89. Boehringer Ingelheim Revenue in Addison's Disease Treatment Business (2016-2021) & (US$ Million)
Table 90. Boehringer Ingelheim Recent Development
Table 91. Amgen Company Details
Table 92. Amgen Business Overview
Table 93. Amgen Addison's Disease Treatment Product
Table 94. Amgen Revenue in Addison's Disease Treatment Business (2016-2021) & (US$ Million)
Table 95. Amgen Recent Development
Table 96. Lupin Pharmaceuticals Company Details
Table 97. Lupin Pharmaceuticals Business Overview
Table 98. Lupin Pharmaceuticals Revenue in Addison's Disease Treatment Business (2016-2021) & (US$ Million)
Table 99. Lupin Pharmaceuticals Recent Development
Table 100. Research Programs/Design for This Report
Table 101. Key Data Information from Secondary Sources
Table 102. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Addison's Disease Treatment Market Share by Type: 2020 VS 2027
Figure 2. Oral Corticosteroid Features
Figure 3. Corticosteroid Injections Features
Figure 4. Global Addison's Disease Treatment Market Share by Application: 2020 VS 2027
Figure 5. Hospitals Case Studies
Figure 6. Clinics Case Studies
Figure 7. Others Case Studies
Figure 8. Addison's Disease Treatment Report Years Considered
Figure 9. Global Addison's Disease Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Addison's Disease Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Addison's Disease Treatment Market Share by Regions: 2020 VS 2027
Figure 12. Global Addison's Disease Treatment Market Share by Regions (2022-2027)
Figure 13. Global Addison's Disease Treatment Market Share by Players in 2020
Figure 14. Global Top Addison's Disease Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Addison's Disease Treatment as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Addison's Disease Treatment Revenue in 2020
Figure 16. Global Addison's Disease Treatment Revenue Market Share by Type (2016-2021)
Figure 17. Global Addison's Disease Treatment Revenue Market Share by Type (2022-2027)
Figure 18. North America Addison's Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Addison's Disease Treatment Market Share by Type (2016-2027)
Figure 20. North America Addison's Disease Treatment Market Share by Application (2016-2027)
Figure 21. North America Addison's Disease Treatment Market Share by Country (2016-2027)
Figure 22. United States Addison's Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Addison's Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Addison's Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Addison's Disease Treatment Market Share by Type (2016-2027)
Figure 26. Europe Addison's Disease Treatment Market Share by Application (2016-2027)
Figure 27. Europe Addison's Disease Treatment Market Share by Country (2016-2027)
Figure 28. Germany Addison's Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Addison's Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Addison's Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Addison's Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Addison's Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Addison's Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Addison's Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Addison's Disease Treatment Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Addison's Disease Treatment Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Addison's Disease Treatment Market Share by Region (2016-2027)
Figure 38. China Addison's Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Addison's Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Addison's Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Addison's Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Addison's Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Addison's Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Addison's Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Addison's Disease Treatment Market Share by Type (2016-2027)
Figure 46. Latin America Addison's Disease Treatment Market Share by Application (2016-2027)
Figure 47. Latin America Addison's Disease Treatment Market Share by Country (2016-2027)
Figure 48. Mexico Addison's Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Addison's Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Addison's Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Addison's Disease Treatment Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Addison's Disease Treatment Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Addison's Disease Treatment Market Share by Country (2016-2027)
Figure 54. Turkey Addison's Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Addison's Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Addison's Disease Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Pfizer Revenue Growth Rate in Addison's Disease Treatment Business (2016-2021)
Figure 58. GlaxoSmithKline Revenue Growth Rate in Addison's Disease Treatment Business (2016-2021)
Figure 59. Takeda Revenue Growth Rate in Addison's Disease Treatment Business (2016-2021)
Figure 60. Abbott Laboratories Revenue Growth Rate in Addison's Disease Treatment Business (2016-2021)
Figure 61. Merck Revenue Growth Rate in Addison's Disease Treatment Business (2016-2021)
Figure 62. Boehringer Ingelheim Revenue Growth Rate in Addison's Disease Treatment Business (2016-2021)
Figure 63. Amgen Revenue Growth Rate in Addison's Disease Treatment Business (2016-2021)
Figure 64. Lupin Pharmaceuticals Revenue Growth Rate in Addison's Disease Treatment Business (2016-2021)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed

---